- Products | Endo
Discover Endo's comprehensive range of high-quality healthcare products, meticulously designed to meet the needs of patients across the U S This product information is intended for U S residents
- Mallinckrodt and Endo to Combine to Create a Global, Scaled . . .
Mallinckrodt and Endo plan to combine their generic pharmaceuticals businesses and Endo's sterile injectables business after the close of the transaction and intend to separate that business from the combined company at a later date
- Focus Areas | Endo
Endo is boldly innovating in pursuit of transforming health and health system burdens Through our long-standing work in endocrinology, orthopedics, and urology, as well as in hospital systems and with retail generic medications, we have developed an unmatched understanding of those we serve
- Careers | Endo
Beware of fraudulent recruiters falsely claiming to represent Endo We never send payments for equipment or request personal financial information during recruitment
- New Corporate Brand and Website, Uniting as One Endo | Endo
Our New Website In April 2024, we debuted our new corporate website, which illustrates that Endo is “Inspired for Life,” with expressions and experiences of life—emotions, relationships, and health The story of our vision, impact, and culture is told through a new anthem video
- Home | Endo
At Endo, our dedication extends beyond developing quality products With a rich history, we empower individuals and communities alike, fostering better health outcomes and a brighter future for all
- Endo Announces Divestiture of International Pharmaceuticals Business
Endo is a diversified pharmaceutical company boldly transforming insights into life-enhancing therapies Our passionate team members collaborate to develop and deliver these essential medicines
- Mallinckrodt and Endo Announce Significant Progress in Proposed Merger
As announced on March 13, 2025, the proposed Mallinckrodt and Endo transaction envisions the spin-off of the combined generic pharmaceuticals businesses and Endo's sterile injectables business into a new standalone entity separate from the remaining branded pharmaceuticals business
|